Goldman Sachs: “Additional fiscal support still looks likely but Congress has made virtually no progress since the election. With Congress now on Thanksgiving recess this further reduces the odds that Congress will pass major COVID relief legislation in December. Instead, it looks more likely that Congress will add provisions to the spending bill…[Read more]

Goldman Sachs: “They expect to supply globally up to 50mn vaccine doses in 2020 and manufacture up to 1.3bn doses in 2021. Based on PFE/BNTX dosing schedule each person will require two doses.PFE noted on the company’s 3Q earnings call that they expect to provide 30-40mn doses in the US by the end of 2020 assuming they receive approval and the…[Read more]

Goldman Sachs: GS cross-asset macro conf call yesteday focusing on read-across the election can be summarized like this: “no change”. Nothing to see here, circulate back to CB BS….

Key message is that “our forecasts look about right” and there seems to be very little need to change anything.

Economics: current forecasts look about right. If…[Read more]